Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B.
D000666:Amphotericin B / Q000494:pharmacology*; D000818:Animals; D002277:Carcinoma; D002460:Cell Line; D002470:Cell Survival; D003470:Culture Media; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006367:HeLa Cells; D006801:Humans; D007739:L Cells; D007930:Leucine / Q000378:metabolism; D051379:Mice; D009062:Mouth Neoplasms; D011113:Polymyxins / Q000494:pharmacology*; D014176:Protein Biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology*; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D003470:Culture Media; D011113:Polymyxins; D012334:RNA, Neoplasm; D014316:Tritium; D000666:Amphotericin B; D013752:Tetracycline; D007930:Leucine; D012293:Rifampin; D014529:Uridine